Coherus Oncology, Inc. (CHRS) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $1.43 | +472.0% |
| 2024 | $0.25 | +109.9% |
| 2023 | $-2.53 | +32.7% |
| 2022 | $-3.76 | +1.3% |
| 2021 | $-3.81 | -335.2% |
| 2020 | $1.62 | +31.7% |
| 2019 | $1.23 | +138.2% |
| 2018 | $-3.22 | +28.1% |
| 2017 | $-4.48 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $1.43 | +472.0% |
| 2024 | $0.25 | +109.9% |
| 2023 | $-2.53 | +32.7% |
| 2022 | $-3.76 | +1.3% |
| 2021 | $-3.81 | -335.2% |
| 2020 | $1.62 | +31.7% |
| 2019 | $1.23 | +138.2% |
| 2018 | $-3.22 | +28.1% |
| 2017 | $-4.48 | — |